User profiles for Wanheng Zhang
 | Wanheng ZhangUniversity of Texas Health Science Center at Houston Verified email at uth.tmc.edu Cited by 59 |
Discovery of small molecules simultaneously targeting NAD (P) H: quinone oxidoreductase 1 and nicotinamide phosphoribosyltransferase: treatment of drug-resistant …
K Zhang, K Wang, X Zhang, Z Qian… - Journal of Medicinal …, 2022 - ACS Publications
Targeting NAD + metabolism has emerged as an effective anticancer strategy. Inspired by
the synergistic antitumor effect between NAD(P)H:quinone oxidoreductase 1 (NQO1) …
the synergistic antitumor effect between NAD(P)H:quinone oxidoreductase 1 (NQO1) …
[HTML][HTML] Recurrent neural network models (CovRNN) for predicting outcomes of patients with COVID-19 on admission to hospital: model development and validation …
Background Predicting outcomes of patients with COVID-19 at an early stage is crucial for
optimised clinical care and resource management, especially during a pandemic. Although …
optimised clinical care and resource management, especially during a pandemic. Although …
A PDA‐Functionalized 3D Lung Scaffold Bioplatform to Construct Complicated Breast Tumor Microenvironment for Anticancer Drug Screening and Immunotherapy
2D cell culture occupies an important place in cancer progression and drug discovery
research. However, it limitedly models the “true biology” of tumors in vivo. 3D tumor culture …
research. However, it limitedly models the “true biology” of tumors in vivo. 3D tumor culture …
Dual nicotinamide phosphoribosyltransferase and epidermal growth factor receptor inhibitors for the treatment of cancer
W Zhang, K Zhang, Y Yao, Y Liu, Y Ni, C Liao… - European Journal of …, 2021 - Elsevier
Multitarget drugs have emerged as a promising treatment modality in modern anticancer
therapy. Taking advantage of the synergy of NAMPT and EGFR inhibition, we have developed …
therapy. Taking advantage of the synergy of NAMPT and EGFR inhibition, we have developed …
Discovery of small-molecule inhibitors of the PD-1/PD-L1 axis that promote PD-L1 internalization and degradation
T Wang, S Cai, Y Cheng, W Zhang… - Journal of medicinal …, 2022 - ACS Publications
Several monoclonal antibodies targeting the programmed cell death-1/programmed cell
death-ligand 1 (PD-1/PD-L1) pathway have been used successfully in anticancer …
death-ligand 1 (PD-1/PD-L1) pathway have been used successfully in anticancer …
Novel biphenyl pyridines as potent small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 interaction
…, S Cai, M Wang, W Zhang, K Zhang… - Journal of Medicinal …, 2021 - ACS Publications
With the successful clinical application of anti-programmed cell death-1 (PD-1)/programmed
cell death-ligand 1 (PD-L1) monoclonal antibodies (mAb), targeting the PD-1/PD-L1 …
cell death-ligand 1 (PD-L1) monoclonal antibodies (mAb), targeting the PD-1/PD-L1 …
Phycocyanin-functionalized black phosphorus quantum dots enhance PDT/PTT therapy by inducing ROS and irreparable DNA damage
W Zhang, L Yu, Y Jiang, C Guo - Biomaterials Science, 2021 - pubs.rsc.org
To achieve synergistic photodynamic–photothermic therapy, we fabricate the novel
phycocyanin (PC)-functionalized black phosphorus quantum dots (BPQDs) referred as PC@BPQDs …
phycocyanin (PC)-functionalized black phosphorus quantum dots (BPQDs) referred as PC@BPQDs …
The multiple regulation of metastasis suppressor NM23-H1 in cancer
Metastasis is one of the leading causes of mortality in cancer patients. As the firstly identified
metastasis suppressor, NM23-H1 has been endowed with expectation as a potent target in …
metastasis suppressor, NM23-H1 has been endowed with expectation as a potent target in …
New phenotype discovery method by unsupervised deep representation learning empowers genetic association studies of brain imaging
Understanding the genetic architecture of brain structure is challenging, partly due to difficulties
in designing robust, non-biased descriptors of brain morphology. Until recently, brain …
in designing robust, non-biased descriptors of brain morphology. Until recently, brain …
Design, synthesis, biological evaluation of urea substituted 1, 2, 5-oxadiazole-3-carboximidamides as novel indoleamine 2, 3-dioxygenase-1 (IDO1) inhibitors
…, L Wang, W Zhang, S Jiang, X Zhang, K Zhang - European Journal of …, 2023 - Elsevier
Indoleamine 2,3-dioxygenase-1 (IDO1) has been considered as an attractive target for
oncology immunotherapy due to its immunosuppressive effects on the tumor microenvironment. …
oncology immunotherapy due to its immunosuppressive effects on the tumor microenvironment. …